TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20379892

Group type: EXPERIMENTAL
Intervention: Body size perceptions related to health and wealth
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Perceived body size preference among Pakistanis in Norway
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Discrepancy score between self-rated body size and perceived body size preference
Number of subjects: 198
Study: 18590345

Group type: EXPERIMENTAL
Intervention: Lansoprazole 0.5 mg/kg/day (neonates)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lansoprazole 1.0 mg/kg/day (neonates)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lansoprazole 1.0 mg/kg/day (infants)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Lansoprazole 2.0 mg/kg/day (infants)
Number of subjects: 48
Study: 15849809

Group type: EXPERIMENTAL
Intervention: Proglumide treatment group (0.4 g proglumide thrice daily for more than 5 years)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Control group (operation only)
Number of subjects: 301
Study: 12745495

Group type: EXPERIMENTAL
Intervention: Oral transmucosal nicotine (OT‐NIC) lozenge (4 mg)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: OT‐NIC (various flavors)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: OT‐NIC
Number of subjects: 11
Study: 11056094

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitors or AT1-R antagonists
Number of subjects: 12

Group type: COMPARATOR
Intervention: Healthy subjects
Number of subjects: 12
Study: 8647754

Group type: EXPERIMENTAL
Intervention: co-amoxiclav (79 patients)
Number of subjects: 165

Group type: COMPARATOR
Intervention: phenoxymethyl penicillin (86 patients)
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: beta-lactamase activity
Number of subjects: 165
Study: 1561294

Group type: EXPERIMENTAL
Intervention: Preventive health screening and health education
Number of subjects: 0
Study: 4034622

Group type: EXPERIMENTAL
Intervention: 5 mg methylphenidate hydrochloride (Ritalin)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 10 mg methylphenidate hydrochloride (Ritalin)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15 mg methylphenidate hydrochloride (Ritalin)
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 30160980

Group type: EXPERIMENTAL
Intervention: Serological biomarkers of collagen formation (PRO-C3)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Serological biomarkers of collagen degradation (C6M)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low levels of PRO-C5
Number of subjects: 0
Study: 30382891

Group type: EXPERIMENTAL
Intervention: Personalized dosage of morphine during the procedure when VAS ≥4
Number of subjects: 100

Group type: COMPARATOR
Intervention: 5 mg of morphine intravenously, followed by 10 mg of morphine subcutaneously 30 min before surgery (Control group)
Number of subjects: 100
Study: 26808848

Group type: EXPERIMENTAL
Intervention: 12 g of citrulline-malate (CM)
Number of subjects: 10

Group type: COMPARATOR
Intervention: lemon sugar-free cordial (placebo)
Number of subjects: 10
Study: 23861240

Group type: EXPERIMENTAL
Intervention: Pay-for-performance (P4P) incentives
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control for selection on observables and unobservables
Number of subjects: 0
Study: 22458601

Group type: EXPERIMENTAL
Intervention: Hawthorn extract (1000 mg, 1500 mg, and 2500 mg)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 20664903

Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg daily
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily
Number of subjects: 101

Group type: COMPARATOR
Intervention: Dual antiplatelet therapy (ASA and clopidogrel)
Number of subjects: 101
Study: 17985535

Group type: EXPERIMENTAL
Intervention: Low frequency electrical stimulation for 1 hour after surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unstimulated)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low frequency electrical stimulation
Number of subjects: 0
Study: 15567543

Group type: EXPERIMENTAL
Intervention: Knee osteoarthritis group (n = 26)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Age-matched healthy adults (n = 20)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Young adults (n = 20)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Biceps femoris to vastus lateralis ratio
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: EMG activity of vastus lateralis
Number of subjects: 66
Study: 11940275

Group type: EXPERIMENTAL
Intervention: Eight-session group intervention
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Four-session group intervention
Number of subjects: 360

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 360
Study: 10463323

Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 8580690

Group type: EXPERIMENTAL
Intervention: Chinese medicinal herbs and chemotherapy on the first postoperational day
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine treatment two weeks later (Control)
Number of subjects: 84
Study: 2356909

Group type: EXPERIMENTAL
Intervention: Experimental educational day care program
Number of subjects: 86

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 86
Study: 384024

Group type: EXPERIMENTAL
Intervention: 2 mg. butorphanol
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: 4 mg. butorphanol
Number of subjects: 81

Group type: COMPARATOR
Intervention: 80 mg. meperidine
Number of subjects: 81
Study: 29463420

Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KIN)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Paraffin (PARA)
Number of subjects: 110
Study: 28987237

Group type: EXPERIMENTAL
Intervention: Home-based exercise intervention
Number of subjects: 123

Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 123
Study: 25552526

Group type: EXPERIMENTAL
Intervention: Home-based respiratory muscle training with progressively increased resistance from 30% to 75% of each patient's maximum respiratory pressure, 6 times a week for 4 months
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group used a fixed resistance of 9 centimeters of water, 6 times a week for 4 months
Number of subjects: 18
Study: 25268437

Group type: EXPERIMENTAL
Intervention: Virtual ward
Number of subjects: 1923

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1923
Study: 22103436

Group type: EXPERIMENTAL
Intervention: Initial monotherapy
Number of subjects: 497

Group type: COMPARATOR
Intervention: Combination therapy
Number of subjects: 497
Study: 19467415

Group type: EXPERIMENTAL
Intervention: Tongue base radiofrequency reduction
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tongue base suspension
Number of subjects: 57

Group type: COMPARATOR
Intervention: Obese patients (tongue base radiofrequency reduction)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Obese patients (tongue base suspension)
Number of subjects: 57
Study: 17612946

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 30 mg/day (bedtime dosing)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS 60 mg/day (bedtime dosing)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS (bedtime dosing)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nifedipine GITS 30 mg/day (morning dosing)
Number of subjects: 80
Study: 15042461

Group type: EXPERIMENTAL
Intervention: MR-myelography
Number of subjects: 1022

Group type: COMPARATOR
Intervention: Conventional MR examination
Number of subjects: 1022
Study: 11750840

Group type: EXPERIMENTAL
Intervention: Oral topotecan, 2.3 mg/m(2)/day for 5 days every 21 days
Number of subjects: 266

Group type: COMPARATOR
Intervention: Intravenous topotecan, 1.5 mg/m(2)/day for 5 days every 21 days
Number of subjects: 266
Study: 9717776

Group type: EXPERIMENTAL
Intervention: Standardized information about colonoscopy plus additional sensory information describing what they could expect to feel (for information seekers)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standardized information about colonoscopy (for information avoiders)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Standardized information about colonoscopy congruent with coping style
Number of subjects: 80

Group type: COMPARATOR
Intervention: Standardized information about colonoscopy not congruent with coping style
Number of subjects: 80
Study: 8984044

Group type: EXPERIMENTAL
Intervention: Single dose PRP-T vaccine
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Associated with DPT vaccine
Number of subjects: 125
Study: 2803579

Group type: EXPERIMENTAL
Intervention: sulbactam/ampicillin
Number of subjects: 36

Group type: COMPARATOR
Intervention: clindamycin/gentamicin
Number of subjects: 36
Study: 7448509

Group type: EXPERIMENTAL
Intervention: Antiseptic skin preparation and daily care of the cannula site
Number of subjects: 50

Group type: COMPARATOR
Intervention: No skin preparation before or after cannula insertion
Number of subjects: 50
Study: 31873920

Group type: EXPERIMENTAL
Intervention: End of rotation evaluations
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Patient care and medical knowledge competencies
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Systems-based practice and practice-based learning and improvement competencies
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Higher number of available evaluations
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: End of rotation evaluations and clinical skills examinations
Number of subjects: 2
Study: 29635402

Group type: EXPERIMENTAL
Intervention: D+E (diet-induced weight loss and exercise)
Number of subjects: 454

Group type: COMPARATOR
Intervention: D (diet-induced weight loss)
Number of subjects: 454

Group type: COMPARATOR
Intervention: E (exercise)
Number of subjects: 454

Group type: EXPERIMENTAL
Intervention: Self-efficacy
Number of subjects: 454
Study: 25807867

Group type: EXPERIMENTAL
Intervention: SBT complex
Number of subjects: 0

Group type: COMPARATOR
Intervention: Emollient base
Number of subjects: 0
Study: 23618743

Group type: EXPERIMENTAL
Intervention: Laparoscopic sacropexy
Number of subjects: 262

Group type: COMPARATOR
Intervention: Vaginal mesh
Number of subjects: 262
Study: 21372306

Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control
Number of subjects: 44
Study: 19538486

Group type: EXPERIMENTAL
Intervention: HBsAg(+) grafts
Number of subjects: 373

Group type: COMPARATOR
Intervention: HBsAg(-) grafts
Number of subjects: 373
Study: 19248718

Group type: EXPERIMENTAL
Intervention: Audio computer‐assisted self‐interview (ACASI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional face‐to‐face (FTF) interview
Number of subjects: 0
Study: 15380117

Group type: EXPERIMENTAL
Intervention: Mozart's Sonata for Two Pianos (K448)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control music (Beethoven's Für Elise)
Number of subjects: 4
Study: 11682346

Group type: EXPERIMENTAL
Intervention: 0.5 Hz CES
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 100 Hz CES
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham CES
Number of subjects: 12
Study: 9709278

Group type: EXPERIMENTAL
Intervention: Mammographic screening (invited between 1978 and 1990 for MMST II, and not invited until 1991-1994 for control group in MMST I)
Number of subjects: 25870

Group type: COMPARATOR
Intervention: Control group (not invited for examination until four years after the code was broken in MMST I)
Number of subjects: 25870
Study: 8325178

Group type: EXPERIMENTAL
Intervention: Dopamine (50 micrograms)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Metoclopramide (500 micrograms)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Physiological saline (Control group)
Number of subjects: 27
Study: 3539614

Group type: COMPARATOR
Intervention: Tiapamil 600 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Tiapamil 800 mg
Number of subjects: 10
Study: 11213009

Group type: EXPERIMENTAL
Intervention: Two percent lignocaine gel
Number of subjects: 308

Group type: COMPARATOR
Intervention: Inert gel (placebo)
Number of subjects: 308
Study: 30679762

Group type: EXPERIMENTAL
Intervention: Diabetic fasting glucose levels after PCa diagnosis
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Diabetic fasting glucose levels among participants with localized cancer at diagnosis
Number of subjects: 1770

Group type: EXPERIMENTAL
Intervention: Glucose measurements taken up to 5 years earlier
Number of subjects: 1770

Group type: COMPARATOR
Intervention: Diabetic glucose levels measured before the diagnosis
Number of subjects: 1770
Study: 29191649

Group type: EXPERIMENTAL
Intervention: 0.375% ropivacaine, 20 mL plus 1 μg/kg of dexmedetomidine (group RD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.375% ropivacaine, 20 mL only (group R)
Number of subjects: 60
Study: 27429977

Group type: EXPERIMENTAL
Intervention: Absorbable knotless wound closure device
Number of subjects: 62

Group type: COMPARATOR
Intervention: 2‐0 Vicryl suture
Number of subjects: 62
Study: 25376714

Group type: EXPERIMENTAL
Intervention: Assisted self-reduction technique
Number of subjects: 237

Group type: COMPARATOR
Intervention: Traction-countertraction method
Number of subjects: 237
Study: 23294785

Group type: EXPERIMENTAL
Intervention: HumaPen Memoir
Number of subjects: 257

Group type: COMPARATOR
Intervention: HumaPen Luxura
Number of subjects: 257
Study: 21438413

Group type: EXPERIMENTAL
Intervention: Pingchuan water decoction (one tie per day, in four to six-divided doses for eight weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Montelukast Sodium tablets (4 mg for 2-5 years old or 5 mg for 6-14 years old, once every night before sleeping for eight weeks)
Number of subjects: 0
Study: 17682119

Group type: EXPERIMENTAL
Intervention: Glucosamine (500 mg orally three times daily for 2 weeks)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (500 mg orally three times daily for 2 weeks)
Number of subjects: 12
Study: 16205353

Group type: EXPERIMENTAL
Intervention: Prodisc total disc arthroplasty
Number of subjects: 118
Study: 12402261

Group type: EXPERIMENTAL
Intervention: Dopamine cell implantation (DYS+ group)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Dopamine cell implantation (DYS- group)
Number of subjects: 17
Study: 10426383

Group type: EXPERIMENTAL
Intervention: 24-h hyperinsulinemia (30 mU x kg(‐1) x h(‐1))
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 24-h Acipimox (250 mg/4 h)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 24-h hyperinsulinemia
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 24-h Acipimox
Number of subjects: 16
Study: 7770708

Group type: EXPERIMENTAL
Intervention: 30 mg lansoprazole
Number of subjects: 279

Group type: COMPARATOR
Intervention: 20 mg omeprazole
Number of subjects: 279
Study: 2124986

Group type: EXPERIMENTAL
Intervention: 5 micrograms plasma vaccine Pasteur (containing 1% pre-S2)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 20 micrograms plasma vaccine MSD (no pre-S2)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 10 micrograms Pasteur
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: 40 micrograms MSD
Number of subjects: 102
Study: 6893754

Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 28
Study: 30412772

Group type: EXPERIMENTAL
Intervention: 3D printing
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (no 3D printing)
Number of subjects: 20
Study: 27848089

Group type: EXPERIMENTAL
Intervention: Cognitive behavioral intervention (Life-Steps) with four initial and two booster sessions delivered by nurses.
Number of subjects: 50

Group type: COMPARATOR
Intervention: Time and session-matched comparison counseling intervention.
Number of subjects: 50
Study: 26023638

Group type: EXPERIMENTAL
Intervention: Synergy low frictional elastomeric rings
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional elastomeric rings
Number of subjects: 30
Study: 23381694

Group type: EXPERIMENTAL
Intervention: Zibotentan 10 mg once daily
Number of subjects: 1421

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1421
Study: 21972820

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 110 mg twice daily
Number of subjects: 9522

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 150 mg twice daily
Number of subjects: 9522

Group type: EXPERIMENTAL
Intervention: Dabigatran etexilate (DE) 75 mg twice daily (simulated for severely renally impaired patients)
Number of subjects: 9522
Study: 19177542

Group type: EXPERIMENTAL
Intervention: Progressive quadriceps strengthening with neuromuscular electrical stimulation (NMES)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Progressive quadriceps strengthening without NMES (volitional strength training)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard of care (conventional rehabilitation)
Number of subjects: 200
Study: 17522388

Group type: EXPERIMENTAL
Intervention: High HDL-C
Number of subjects: 27074

Group type: COMPARATOR
Intervention: Low HDL-C
Number of subjects: 27074
Study: 15457809

Group type: EXPERIMENTAL
Intervention: Gestures during speech production
Number of subjects: 0

Group type: COMPARATOR
Intervention: Gesture restriction
Number of subjects: 0
Study: 11350844

Group type: EXPERIMENTAL
Intervention: Intramuscular gold (GST)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Both GST and MTX
Number of subjects: 141
Study: 9394106

Group type: EXPERIMENTAL
Intervention: Paromomycin sulfate (3 x 1 g/day)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 7699154

Group type: EXPERIMENTAL
Intervention: Pefloxacin (800 mg i.v. OD for 4 days)
Number of subjects: 559

Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with teicoplanin (800 mg i.v. OD) and netilmicin (300 mg i.m. OD)
Number of subjects: 559

Group type: COMPARATOR
Intervention: Thymostimulin (70 mg i.m. OD for the first month and every other day thereafter until discharge)
Number of subjects: 559

Group type: COMPARATOR
Intervention: Control group (no thymostimulin)
Number of subjects: 559
Study: 3582478

Group type: EXPERIMENTAL
Intervention: Propranolol 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31188232

Group type: EXPERIMENTAL
Intervention: Dose reduction group (n = 17)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Dose maintenance group (n = 18)
Number of subjects: 35
Study: 28294958

Group type: EXPERIMENTAL
Intervention: Laparoscopic Nissen fundoplication (LNF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Conventional Nissen fundoplication (CNF)
Number of subjects: 111

Group type: COMPARATOR
Intervention: CNF
Number of subjects: 111
Study: 24496587

Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Early cord clamping (ECC)
Number of subjects: 100
Study: 23636032

Group type: EXPERIMENTAL
Intervention: Mind-body medical stress reduction (MBMSR) group program for 8 weeks
Number of subjects: 43
Study: 21352639

Group type: EXPERIMENTAL
Intervention: Olopatadine hydrochloride nasal spray 0.6% (OLO)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Azelastine hydrochloride nasal spray 0.1% (AZE)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Both OLO and AZE
Number of subjects: 129
Study: 19201696

Group type: EXPERIMENTAL
Intervention: tamsulosin 0.8 mg once daily (QD)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: alfuzosin 10 mg QD
Number of subjects: 48

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: tamsulosin
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: alfuzosin
Number of subjects: 48
Study: 17113722

Group type: EXPERIMENTAL
Intervention: Oral sodium phosphate (NaP)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Polyethylene glycol (PEG)
Number of subjects: 57
Study: 15336247

Group type: EXPERIMENTAL
Intervention: Right visual field (left hemisphere) word presentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unconscious word reading
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Testing a split-brain patient
Number of subjects: 0
Study: 10895373

Group type: EXPERIMENTAL
Intervention: 7-day fasting
Number of subjects: 23

Group type: COMPARATOR
Intervention: 7-day ketogenic diet
Number of subjects: 23
Study: 8777471

Group type: COMPARATOR
Intervention: Losartan 50 mg + Placebo
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + HCTZ 6.25 mg
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + HCTZ 12.5 mg
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg + HCTZ 25 mg
Number of subjects: 312
Study: 1538443

Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (20 micrograms/ml)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Papaverine hydrochloride (30 mg/ml)
Number of subjects: 52
Study: 6520866

Group type: EXPERIMENTAL
Intervention: Finger temperature biofeedback
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Frontalis EMG biofeedback
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Autogenic training
Number of subjects: 24
Study: 31732303

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied to one ear (Group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation (TENS) applied to both ears (Group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo group (Group C)
Number of subjects: 60
Study: 30845829

Group type: EXPERIMENTAL
Intervention: Wristband accelerometer with activity-dependent vibration alerts
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham wristband
Number of subjects: 33
Study: 27619008

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing using only the decisional balance component (MIDB)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Health education around smoking cessation (HE)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Both groups (MIDB and HE)
Number of subjects: 82
Study: 25287585

Group type: EXPERIMENTAL
Intervention: Monitoring
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Discipline
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Skill encouragement
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Problem solving
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Mother-reported monitoring
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Father-reported discipline
Number of subjects: 83
Study: 23859475

Group type: EXPERIMENTAL
Intervention: Cognitive stimulation intervention for resolving delirium in people with dementia
Number of subjects: 0